泰尔股份(002347) - 2025 Q3 - 季度财报

Financial Performance - Q3 2025 revenue reached ¥262,317,964.36, an increase of 2.77% year-over-year[4] - Net profit attributable to shareholders was -¥34,304,230.24, a decrease of 485.16% compared to the same period last year[4] - Total operating revenue for the period reached ¥823,102,761.61, an increase from ¥737,713,320.79 in the previous period, representing a growth of approximately 11.6%[18] - The company reported a net loss of ¥58,329,228.21, compared to a net loss of ¥11,319,381.95 in the previous period, indicating a significant decline in profitability[19] - Operating profit was recorded at -¥56,999,433.87, a sharp decrease from -¥7,208,335.57 in the prior year, reflecting ongoing operational challenges[19] - The company reported a total comprehensive loss of ¥58,152,188.45, compared to a loss of ¥11,310,237.29 in the previous period, highlighting deteriorating financial health[19] - Basic and diluted earnings per share were both -¥0.1064, worsening from -¥0.0313 in the prior year[19] Cash Flow and Financing - The net cash flow from operating activities for the year-to-date was -¥100,942,372.59, down 15.57%[4] - Cash flow from financing activities increased by 615.98% to ¥71,444,658.97, reflecting new bank loans obtained[9] - The company generated ¥61,000,000.00 in cash from borrowings, compared to ¥30,000,000.00 in the previous period, indicating increased reliance on debt financing[20] - The company experienced a net cash outflow from operating activities of -¥100,942,372.59, worsening from -¥87,342,158.62 in the previous period[20] - Investment activities yielded a net cash inflow of ¥1,724,621.48, down from ¥5,772,337.25, reflecting reduced investment returns[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,405,162,091.41, a decrease of 6.30% from the previous year-end[4] - Total assets decreased to ¥2,405,162,091.41 from ¥2,566,791,973.96, a decline of about 6.3%[16] - Total liabilities decreased to ¥1,231,423,287.13 from ¥1,325,126,830.65, a reduction of approximately 7.1%[17] - The company's equity attributable to shareholders decreased to ¥1,144,551,183.75 from ¥1,207,827,403.88, a decline of about 5.2%[17] - The company’s total liabilities increased, contributing to a challenging financial position moving forward[19] Operating Costs and Expenses - Total operating costs amounted to ¥870,486,728.42, up from ¥758,425,945.31, indicating a rise of about 14.7%[18] - Operating costs included ¥701,723,410.14 in cost of goods sold, which increased from ¥586,014,551.73, reflecting a growth of approximately 19.7%[18] - Research and development expenses were ¥55,592,955.43, compared to ¥51,186,163.01 in the previous period, marking an increase of about 8.4%[18] Investment and Impairment - Investment income decreased by 64.42% to ¥4,761,464.07, primarily due to reduced distributions from a previous investment[9] - The company experienced a 370.71% increase in asset impairment losses, totaling -¥10,014,477.51, attributed to increased inventory write-downs[9] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 77,948[10] - Cash and cash equivalents decreased to ¥333,577,238.23 from ¥411,123,395.28, a decline of approximately 18.9%[15] - Accounts receivable rose to ¥765,470,011.12 from ¥702,971,103.53, an increase of about 8.9%[15] - Inventory decreased to ¥419,100,876.36 from ¥485,979,647.97, a reduction of approximately 13.7%[15] - Cash and cash equivalents at the end of the period stood at ¥254,839,302.56, a decrease from ¥281,915,344.49 at the beginning of the period[21]